SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-16-077753
Filing Date
2016-01-29
Accepted
2016-01-29 10:20:46
Documents
2
Group Members
CORA MADSENFLORIAN SCHONHARTINGNB PUBLIC EQUITY KOMPLEMENTAR APS

Document Format Files

Seq Description Document Type Size
1 SC 13G v430010_sc13g.htm SC 13G 58748
2 EXHIBIT 99.1 v430010_ex99-1.htm EX-99.1 8612
  Complete submission text file 0001144204-16-077753.txt   69027
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48459 | Film No.: 161371369
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address OSTERGADE 5 3RD FLOOR DK-1100 COPENHAGEN K G7 -----
Business Address OSTERGADE 5 3RD FLOOR DK-1100 COPENHAGEN K G7 ----- 45 70 20 12 63
NB Public Equity K/S (Filed by) CIK: 0001451330 (see all company filings)

IRS No.: 000000000
Type: SC 13G